Fresenius posted lower profits for the second quarter due to rising costs, higher taxes and negative developments at its hospital subsidiary, but its dialysis business posted positive results, with underlying earnings of €401 million.
Fresenius posted lower profits for the second quarter due to rising costs, higher taxes and negative developments at its hospital subsidiary, but its dialysis business posted positive results, with underlying earnings of €401 million.